2nd Quarter - Termination — CAPITOL PARTNERS, LLC for CMC PHARMA (2022)

Firm

CAPITOL PARTNERS, LLC

Client

CMC PHARMA

Income

$7,500

Expenses

—

Terminated

Apr 4, 2022

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

supporting covid vaccine research and programs; defense funding to support innovations in medical countermeasures

Lobbyist	Covered position, as disclosed
DORA J. PRUCE	—

Contacted: Defense Threat Reduction Agency (DTRA); Small Business Administration (SBA); Defense Advanced Research Projects Agency (DARPA); SENATE

Science/Technology SCI

funding to support vaccine research/innovations in medical countermeasures

Lobbyist	Covered position, as disclosed
DORA J. PRUCE New	—

Contacted: SENATE

Small Business SMB

innovations in medical countermeasures/research funding for vaccines

Lobbyist	Covered position, as disclosed
DORA J. PRUCE	—

Contacted: Defense Threat Reduction Agency (DTRA); SENATE; HOUSE OF REPRESENTATIVES; Defense Advanced Research Projects Agency (DARPA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.